Image For Activity Cover
AACE Master Class: Management of Prolactin - and GH - Secreting Adenomas During Pregnancy
Speaker Bio
Document LearningActivityInformation 3520
Mark Molitch, M.D. is Professor Emeritus in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. He has participated in clinical research for many years, focusing on the pathogenesis of pituitary tumors and their treatment. He has also had a long-standing interest in the interaction between pituitary tumors and pregnancy. He has been involved in most of the initial trials of therapeutic agents for pituitary tumors, including those using bromocriptine, mesulergine, quinagolide, cabergoline, octreotide, octreotide-LAR, oral octreotide, lanreotide and mifepristone. He was also PI of the Northwestern University Center of The Testosterone Trials.

Dr. Molitch has been a member of the committees that wrote many current clinical guidelines used by endocrinologists, including those for Adult Growth Hormone Deficiency, Prolactinomas, Acromegaly, Pituitary Incidentalomas, Diabetes (Standards of Care), and Diabetic Nephropathy. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 500 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society and was President of the Pituitary Society in 2012-2013.
Summary
Availability: On-Demand
Expires on May 11, 2023
Cost: Member: $25.00
Non-Member: $50.00
Credit Offered:
0.75 CME Credit
0.75 ABIM-MOC Point
Powered By